Search Login Register

Mitoguazone (MGBG) Summary

Description: Antineoplastic agent effective against myelogenous leukemia in experimental animals. Also acts as an inhibitor of animal S-adenosylmethionine decarboxylase.

Also Known As: MGBG; Methyl-gag; NSC-32946; Methyl gag; Methylgag Show All >>

Networked: 220 relevant articles (9 outcomes, 63 trials/studies) for this Bio-Agent

Key Diseases for which Mitoguazone is Relevant

  1. Neoplasms (Cancer) : 5 outcomes 16 studies in 69 results
  2. Leukemia : 3 outcomes 3 studies in 20 results
  3. Adenocarcinoma : 2 outcomes 4 studies in 13 results
  4. Psoriasis (Pustulosis Palmaris et Plantaris) : 2 outcomes 1 study in 2 results
  5. Lymphoma (Lymphomas) : 1 outcome 8 studies in 24 results
Show All >>

Drugs Related to Mitoguazone

  1. Mitoguazone (MGBG)
  2. Eflornithine (Ornidyl)
  3. Spermidine
  4. Spermine
  5. Fluorouracil (Carac)
  6. Cisplatin (Platino)
  7. Vinblastine (Vinblastine Sulfate)
  8. Etoposide (VP 16)
  9. Ifosfamide
  10. Methotrexate (Mexate)
Show All >>

Therapies Related to Mitoguazone

  1. Drug Therapy (Chemotherapy)
  2. Combination Drug Therapy (Combination Chemotherapy)
  3. Esophagectomy
  4. Transplantation (Transplant Recipients)
  5. Salvage Therapy
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.